Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$44.46−1.23 (-2.69%)
Close on Nov 13, 2026Market cap $830.51MP/E 2.9Yield –
Rigel Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Rigel Pharmaceuticals's enterprise value was $779.82M on Nov 11, 2026, against $789.77M a year earlier. Over the last 5 years it ranged from $30.75M to $913.30M, with a median of $233.88M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $779.82M | +20.1% |
| 2025 | Dec 31, 2025 | $649.14M | +177.5% |
| 2024 | Dec 31, 2024 | $233.88M | +25.4% |
| 2023 | Dec 29, 2023 | $186.57M | +10.2% |
| 2022 | Dec 30, 2022 | $169.37M | -45.6% |
| 2021 | Dec 31, 2021 | $311.45M | -39.8% |
| 2020 | Dec 31, 2020 | $517.46M | +106.4% |
| 2019 | Dec 31, 2019 | $250.75M | +43.4% |
| 2018 | Dec 31, 2018 | $174.91M | -41.3% |
| 2017 | Dec 29, 2017 | $298.15M | +138.1% |
| 2016 | Dec 30, 2016 | $125.22M | -4.6% |
| 2015 | Dec 31, 2015 | $131.27M | +224.3% |
| 2014 | Dec 31, 2014 | $40.47M | – |
| 2013 | Dec 31, 2013 | -$17.23M | -106.1% |
| 2012 | Dec 31, 2012 | $282.55M | -48.0% |
| 2011 | Dec 30, 2011 | $543.35M | +85.4% |
| 2010 | Dec 31, 2010 | $293.08M | – |
See a number that looks wrong?